Histiocytosis
6 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| FOLFIRI + FOLFOX6/FOLFOX7 + S241656 + PANITUMUMAB + Cetuximab for histiocytosis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Lenalidomide for erdheim-chester disease | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| S241656 for histiocytosis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| S241656 + PEMBROLIZUMAB for histiocytosis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| S241656 + Trametinib for histiocytosis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Trametinib + DABRAFENIB for erdheim-chester disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |